首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >FORMULATION, CHARACTERIZATION AND IN-VIVO APPLICATION OF ORAL INSULIN NANOTECHNOLOGY USING DIFFERENT BIODEGRADABLE POLYMERS: ADVANCED DRUG DELIVERY SYSTEM
【24h】

FORMULATION, CHARACTERIZATION AND IN-VIVO APPLICATION OF ORAL INSULIN NANOTECHNOLOGY USING DIFFERENT BIODEGRADABLE POLYMERS: ADVANCED DRUG DELIVERY SYSTEM

机译:使用不同生物可降解聚合物的口服胰岛素纳米技术的配制,表征和体内应用:先进的药物输送系统

获取原文
           

摘要

The overall objective of this research is to improve the oral bioavailability of insulin through encapsulation in nanoparticles formulated by “ionotropic pre-gelation followed by polyelectrolyte complexation technique”. The preparation variables such as initial drug concentration, polymer: polymer ratios, crosslinker concentration, stirring speed, stirring time, pH of drug / polymer mixture were investigated to study the effect of variables on nanoparticles size and drug entrapment efficiency. The optimum formula of insulin-loaded nanoparticles was tested for insulin release in three different pH media. The pharmacological activity of insulin-loaded nanoparticles was evaluated following oral dosage in diabetic rats and then study whether insulin-loaded nanoparticles would induce hypoglycemic effect after oral administration to diabetic rats. The optimum formula of nanoparticles improved insulin release characteristics. Thus, the polymer matrix provided protection for insulin in acidic gastric medium and allowed prolonged insulin release in alkaline intestinal medium. emIn-vivo/em results indicated that nanoparticles kept insulin bioactivity and its hypoglycemic effect after oral administration of insulin-loaded nanoparticles to diabetic rat model. It was found that natural biodegradable nanoparticles are a promising device for oral insulin delivery.
机译:这项研究的总体目标是通过将胶囊包封在纳米颗粒中来改善胰岛素的口服生物利用度,所述纳米颗粒通过“离子化预胶凝后再进行聚电解质络合技术”配制而成。研究了制备变量,例如初始药物浓度,聚合物:聚合物比率,交联剂浓度,搅拌速度,搅拌时间,药物/聚合物混合物的pH值,以研究变量对纳米粒子尺寸和药物截留效率的影响。测试了载有胰岛素的纳米颗粒的最佳配方在三种不同pH介质中的胰岛素释放。在糖尿病大鼠中口服给药后,评估了载有胰岛素的纳米颗粒的药理活性,然后研究了在口服给予糖尿病大鼠后,载有胰岛素的纳米颗粒是否会引起降血糖作用。纳米粒子的最佳配方改善了胰岛素释放特性。因此,该聚合物基质为酸性胃介质中的胰岛素提供保护,并允许胰岛素在碱性肠介质中延长释放。 体内结果表明,在糖尿病大鼠模型口服给予胰岛素的纳米颗粒后,纳米颗粒保持了胰岛素的生物活性及其降血糖作用。发现天然的可生物降解的纳米颗粒是用于口服胰岛素递送的有前途的装置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号